Literature DB >> 30430853

Histopathologic Features of Chronic Sinusitis Precipitated by Odontogenic Infection.

Anish Raman1, Peter Papagiannopoulos2, Hannah N Kuhar1, Paolo Gattuso3, Pete S Batra2, Bobby A Tajudeen2.   

Abstract

BACKGROUND: Chronic rhinosinusitis (CRS) is a heterogeneous disease process that can arise in the context of odontogenic disease from the maxillary teeth. The histopathologic features of odontogenic CRS (CRSo) have yet to be determined and may have important implications on disease management and need for escalation of therapy.
OBJECTIVES: The objectives of this study are to characterize the histopathologic features of CRSo and determine whether the inflammatory profile of CRSo contributes to its recalcitrance to medical therapy and need for surgery in a subset of patients with this disease.
METHODS: A structured histopathology report was used to analyze sinus tissue removed during functional endoscopic sinus surgery (FESS). Histopathology variables, Lund-Mackay scores (LMS), and Sinonasal Outcome Test-22 scores were compared among CRSo patients, CRS without nasal polyps (CRSsNP) patients, and CRS with nasal polyps (CRSwNP) patients.
RESULTS: Twenty-three CRSo, 38 CRSwNP, and 53 CRSsNP patients who underwent FESS were analyzed. Compared to CRSsNP, CRSo exhibited increased moderate-severe inflammation (73.9% vs 41.5%, P < .009). Compared to CRSwNP, CRSo had decreased squamous metaplasia (0.0% vs 18.4%, P < .03) and decreased fibrosis (26.1% vs 63.2%, P < .005). Eosinophilia was prevalent in CRSo but to a lesser extent than in CRSwNP (39.1% vs 63.2%, P < .05). CRSo cases had significantly lower mean LMS compared to CRSwNP (7.83 ± 2.77 vs12.18 ± 6.77, P < .005).
CONCLUSION: CRSo exhibits histopathologic features similar to those of CRSsNP with more severe inflammation. Moreover, eosinophilia, which is not typically considered to coexist with CRSo, was present in a large portion of CRSo patients. These findings may help explain at the inflammatory level why select cases of CRSo may be recalcitrant to medical and dental therapy.

Entities:  

Keywords:  Sinonasal Outcome Test-22; chronic disease; chronic rhinosinusitis; functional endoscopic sinus surgery; histology; medical therapy of chronic rhinosinusitis; nasal polyps; odontogenic; sinus surgery; treatment

Mesh:

Year:  2018        PMID: 30430853     DOI: 10.1177/1945892418811210

Source DB:  PubMed          Journal:  Am J Rhinol Allergy        ISSN: 1945-8932            Impact factor:   2.467


  6 in total

1.  A structured histopathology-based analysis of surgical outcomes in chronic rhinosinusitis with and without nasal polyps.

Authors:  Michael J Marino; J Omar Garcia; Matthew Zarka; Devyani Lal
Journal:  Laryngoscope Investig Otolaryngol       Date:  2019-08-21

2.  Treatment and Impacts of Chronic Sinusitis with the Confluence of Biyuan Tongqiao Granules and Saline Nasal Irrigation.

Authors:  Fei Ma; Lian Xu; Ping Ai
Journal:  J Healthc Eng       Date:  2022-03-24       Impact factor: 2.682

Review 3.  Odontogenic Sinusitis: From Diagnosis to Treatment Possibilities-A Narrative Review of Recent Data.

Authors:  Cristian Martu; Maria-Alexandra Martu; George-Alexandru Maftei; Diana Antonela Diaconu-Popa; Luminita Radulescu
Journal:  Diagnostics (Basel)       Date:  2022-06-30

4.  Multiple myeloma and pulmonary aspergillosis: dental treatment prior to chemotherapy and management of post extraction complications.

Authors:  Amy Patrick; Khadeeja Saeed; Navdeep Kumar
Journal:  BMJ Case Rep       Date:  2020-04-15

5.  Histopathology of maxillary sinus mucosa with odontogenic maxillary sinusitis.

Authors:  Kiminori Sato; Shun-Ichi Chitose; Kiminobu Sato; Fumihiko Sato; Takeharu Ono; Hirohito Umeno
Journal:  Laryngoscope Investig Otolaryngol       Date:  2020-03-17

6.  Inflammatory cell predominance and patterns in chronic rhinosinusitis with and without nasal polyposis patients.

Authors:  Michael J Marino; J Omar Garcia; Matthew A Zarka; Devyani Lal
Journal:  Laryngoscope Investig Otolaryngol       Date:  2019-11-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.